• Madhumita Talukdar Gauhati University
  • Ritasree Sarma Gauhati University
  • Shruti Talukdar Gauhati University
  • Archana Yadav Gauhati University
  • Dhruva K Jha Gauhati University
  • Tarun Chandra Bora Gauhati University


Bioactive metabolites, Nocardia cyriacigeorgica, Optimization, Pathogenic bacteria


Objective: An attempt has been made to evaluate the optimal cultural conditions for obtaining high yields of bioactive metabolites.

Methods: A strain of actinobacteria was isolated from the soil sample of Kaziranga National Park of Assam. Strain was identified on the basis of biochemical test as well as 16SrDNA sequence. The strain was tested for antibacterial activity using agar well diffusion method and to enhance its growth and metabolite production, the strain was cultured at different carbon and nitrogen sources and at different pH, salinity and temperature.

Results: The strain was identified as Nocardia cyriacigeorgica. The secondary metabolites exhibited excellent antimicrobial activity against dreaded human pathogenic bacteria Staphylococcus aureus (MTCC 96), Bacillus subtilis (MTCC 441), Escherichia coli (MTCC 739) and Pseudomonas aeruginosa (MTCC 2453). The strain utilized glucose as good carbon source for growth and starch for metabolite production. Soybean meal and beef extract were the nitrogen sources for the elaboration of both growth and bioactive metabolites. The optimum temperature, salinity and pH for growth and bioactive metabolite production of the strain were recorded as 28±2oC, 1.5% and 7.5 respectively.

Conclusion: As our results showed the potency of N. cyriacigeorgica as an antibacterial agent under these optimal conditions, so further study can be carried out in this regard. This is the first report of production of antibacterial compound from this emerging pathogenic strain N. cyriacigeorgica.



Download data is not yet available.


Apostolou A, Bolcen SJ, Dave V, Jani N, Lasker BA, Tan CG, et al. Nocardia cyriacigeorgica infections attributable to unlicensed cosmetic procedures—an emerging public health problem? Clin Infect Dis 2012;55:251–3.

Exmelin L, Malbruny B, Vergnaud M, Provost F, Boiron P, Morel C. Molecular study of nosocomial nocardiosis outbreak involving heart transplant recipients. J Clin Microbiol 1996;34:1014-6.

Kachi S, Okazaki M, Takeda H, Igarashi H, Kobayashi O, Watanabe H, et al. Outbreak of Nocardia farcinica infection with the same pattern in randomly amplified polymorphic DNA analysis. J Hosp Infect 2006;62:502–6.

Wenger PN, Brown JM, McNeil MM, Jarvis WR. Nocardia farcinica sternotomy site infections in patients following open heart surgery. J Infect Dis 1998;178:1539-43.

Gordon RE, Barnett DA, Handerhan JE, Pang CHN. Nocardia coeliaca, Nocardia autotrophica, and the nocardin strain. Int J Syst Bacteriol 1974;24:54–63.

Gonzalez Ochoa A. Virulence of nocardiae. Can J Microbiol 1973;19(8):901–4.

Lechevalier MP, De bievre C, Lechevalier H. Chemotaxonomy of aerobic actinomycetes: phospholipid composition. Biochem Syst Ecol 1977;5:249-60.

Tsuda M, Sato H, Tanaka Y, Yazawa K, Mikami Y, Sasaki T, et al. Brasiliquiones A–C, a new cytotoxic benz [a] anthraquinone with an ethyl group at C-3 from actinomycete Nocardia brasiliensis. J Chem Soc Perkins Trans 1996;1:1773–5.

Momose I, Kinoshita N, Sawa R, Naganawa H, Iinuma H, Hamada M, et al. Nothramicina new anthracycline antibiotic from Nocardia sp. MJ896-43F17. J Antibiot 1998;51:130–5.

Tsuda M, Nemoto A, Komaki H, Tanaka Y, Yazawa K, Mikami Y, et al. Nocarasins A–C, and brasilinolide D, new metabolites from the actinomycete Nocardia brasiliensis. J Nat Prod 1999;62:1640–2.

Komatsu K, Tsuda M, Tanaka Y, Mikami Y, Kobayashi J. SAR studies of brasilicardin A for immunosuppressive and cytotoxic activities. Bioorg Med Chem 2005;13:1507–13.

Mikami Y, Yazawa K, Neomoto A, Komaki H, Tanaka Y, Grafe U. Production of erythromycin E by pathogenic Nocardia brasiliensis. J Antibiot 1999;52:201–2.

Millar BC, Moore JE. Emerging pathogens in infectious diseases: definitions, causes and trends. Rev Med Microbiol 2006;17:101–6.

Robert Schlaberg, Richard C Huard, Phyllis Della-Latta. Nocardia cyriacigeorgica, an emerging pathogen in the united states. J Clin Microbiol 2008;46:265–73.

Yassin AF, Rainey FA, Steiner U. Nocardia cyriacigeorgici sp nov. Int J Syst Evol Microbiol 2001;51:1419–23.

Kachuei R, Emami M, Mirnejad R, Khoobdel M. Diversity and frequency of Nocardia spp. in the soil of Isfahan province. Iran Asian Pac J Trop Biomed 2012;2(6):474-8.

MTCC Actinomycetes: Isolation, screening, identification and gene cloning in Streptomyces. Laboratory Manual. MTCC, IMTECH, Chandigarh; 1998. p. 94.

Kumar V, Bharti A, Gusain O, Bisht GS. An improved method for isolation of genomic DNA from filamentous actinomycetes. J Sci Eng Tech Mgt 2010;2:10-3.

Takahashi Y, Omura S. Isolation of new actinomycetes strains for the screening of new bioactive compounds. J Gen Appl Microbiol 2003;49:141-54.

Rusnak K, Troyanovich J, Mierzwa R, Chu M, Patel M, Weinstein M. An antibiotic with activity against gram-positive bacteria from the gentamicin-producing strain of Micromonospora purpurea. Appl Microbiol Biotechnol 2001;56:502–3.

Demain AL. Pharmaceutically active secondary metabolites of microorganisms. Appl Microbiol Biotechnol 1999;52:455–63.

Gramer A. Antibiotic sensitivity and assay tests. In: Collins CH, Lyne PM, editors. Microbiological methods. London: Butterworth and Co; 2008. p. 235.

Myers N, Mittermeier RA, Mittermeier CG, Gustavo AB, da Fonseca, Kent J. Biodiversity hotspots for conservation priorities. Nat 2000;403:853–8.

Hayakawa M, Yoshida Y, Limura Y. Selective isolation of bioactive soil actinomycetes belonging to the Streptomyces violaceusniger phenotypic cluster. J Appl Microbiol 2004;96:973-81.

Lazzarini A, Cavalette L, Toppo G, Marinelli F. Rare genera of actinomycetes as potential producers of new antibiotics. Ant Van Leeuwenhock 2000;78:399-405.

Sergio Sanchez, Adan Chavez, Angela Forero, Yolanda Garcıa-Huante, Alba Romero, Mauricio Sanchez, et al. Carbon source regulation of antibiotic production. J Antibiot 2010;1–18.

Mellouli L, Ben Ameur-Mehdi R, Sioud S, Salem M, Bejar S. Isolation, purification and partial characterization of antibacterial activities produced by a newly isolated Streptomyces sp. Us 24 strain. Res Microbiol 2003;154:345–52.

Decleva ML, Titus JA, Strohl WR. Nutrient effects on anthracycline production by Steptomyces peuceutius in a defined medium. Can J Microbiol 1985;31:287-94.

Nadia H Noaman, Abdel Fattah, M Khaleafa, Seham H Zaky. Factors affecting antimicrobial activity of Synechococcus leopoliensis. Microbiol Res 2004;159:395-402.

Gupte M, Kulkarni P. A study of anti fungal antibiotic production by Thermomonospora sp MTCC 3340 using full factorial design. J Chem Tech Biotechnol 2003;78:605-10.

Ripa FA, Nikkon F, Zaman S, Khondkar P. Optimal conditions for antimicrobial metabolites production from a new streptomces sp. RUPA-08PR Isolated from Bangladeshi Soil. Mycobiol 2009;37:211-4.

Kavitha A, Vijayalakshmi M. Cultural parameters affecting the production of bioactive metabolites by Nocardia levis MK-VL_113. J Appl Sci Res 2009;5:2138-47.

Korkeala H, Alanko T, Tiusanen T. Effect of sodium nitrate and sodium chloride on growth of lactic acid bacteria. Acta Vet Scand 1992;33:27–32.

Pelczar MJ, Chan ECS, Krieg NR. Microbiology: Concepts and Applications. 5th ed. USA: McGraw-Hill; 1993.



How to Cite

Talukdar, M., R. Sarma, S. Talukdar, A. Yadav, D. K. Jha, and T. C. Bora. “OPTIMIZATION OF PROCESS PARAMETERS FOR THE PRODUCTION OF ANTIBACTERIAL COMPOUND BY A NEWLY ISOLATED NOCARDIA CYRIACIGEORGICA, KD-15 STRAIN FROM KAZIRANGA NATIONAL PARK OF NORTH EAST INDIA”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 3, Mar. 2015, pp. 258-64, https://journals.innovareacademics.in/index.php/ijpps/article/view/4473.



Original Article(s)